These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34401690)

  • 1. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication.
    Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A;
    JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human liver chimeric mouse model for non-alcoholic fatty liver disease.
    Bissig-Choisat B; Alves-Bezerra M; Zorman B; Ochsner SA; Barzi M; Legras X; Yang D; Borowiak M; Dean AM; York RB; Galvan NTN; Goss J; Lagor WR; Moore DD; Cohen DE; McKenna NJ; Sumazin P; Bissig KD
    JHEP Rep; 2021 Jun; 3(3):100281. PubMed ID: 34036256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
    Huang Y; Fu JF; Shi HB; Liu LR
    Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid alterations in chronic liver disease and liver cancer.
    Paul B; Lewinska M; Andersen JB
    JHEP Rep; 2022 Jun; 4(6):100479. PubMed ID: 35469167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The plasma lipidome in acute myeloid leukemia at diagnosis in relation to clinical disease features.
    Pabst T; Kortz L; Fiedler GM; Ceglarek U; Idle JR; Beyoğlu D
    BBA Clin; 2017 Jun; 7():105-114. PubMed ID: 28331812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice.
    Sun C; Guo Y; Cong P; Tian Y; Gao X
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids.
    Ni Y; Wang X; Wu Q; Yao Y; Xu Y; Li Y; Feng Q; Zhou M; Gou X
    Front Endocrinol (Lausanne); 2023; 14():1272214. PubMed ID: 37900123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation-related markers.
    Stankevic E; Israelsen M; Juel HB; Madsen AL; Ängquist L; Aldiss PSJ; Torp N; Johansen S; Hansen CD; Hansen JK; Thorhauge KH; Lindvig KP; Madsen BS; Sulek K; Legido-Quigley C; Thiele MS; Krag A; Hansen T
    Liver Int; 2023 Dec; 43(12):2680-2691. PubMed ID: 37592403
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sowton AP; Padmanabhan N; Tunster SJ; McNally BD; Murgia A; Yusuf A; Griffin JL; Murray AJ; Watson ED
    Mol Genet Metab Rep; 2020 Jun; 23():100580. PubMed ID: 32257815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipidomics analysis reveals efficient storage of hepatic triacylglycerides enriched in unsaturated fatty acids after one bout of exercise in mice.
    Hu C; Hoene M; Zhao X; Häring HU; Schleicher E; Lehmann R; Han X; Xu G; Weigert C
    PLoS One; 2010 Oct; 5(10):e13318. PubMed ID: 20967198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.
    Flores YN; Amoon AT; Su B; Velazquez-Cruz R; Ramírez-Palacios P; Salmerón J; Rivera-Paredez B; Sinsheimer JS; Lusis AJ; Huertas-Vazquez A; Saab S; Glenn BA; May FP; Williams KJ; Bastani R; Bensinger SJ
    Lipids Health Dis; 2021 Oct; 20(1):136. PubMed ID: 34629052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute quantitative lipidomics reveals lipids profiling in liver of mice with early-stage alcoholic liver disease.
    Zhao F; Chen J; Guo R; Zhu J; Gu W; Li S; Li J
    Nutr Metab (Lond); 2022 Jul; 19(1):42. PubMed ID: 35790996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL).
    Mocciaro G; Allison M; Jenkins B; Azzu V; Huang-Doran I; Herrera-Marcos LV; Hall Z; Murgia A; Susan D; Frontini M; Vidal-Puig A; Koulman A; Griffin JL; Vacca M
    Mol Metab; 2023 Jul; 73():101728. PubMed ID: 37084865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A serum lipidomic study of patients with non-alcoholic fatty liver disease].
    Yang RX; Hu CX; Mi YQ; Sun WL; Chen GY; Pan Q; Shen F; Xu GW; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):122-127. PubMed ID: 28297799
    [No Abstract]   [Full Text] [Related]  

  • 20. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease.
    Staufer K; Huber-Schönauer U; Strebinger G; Pimingstorfer P; Suesse S; Scherzer TM; Paulweber B; Ferenci P; Stimpfl T; Yegles M; Datz C; Trauner M
    J Hepatol; 2022 Oct; 77(4):918-930. PubMed ID: 35605744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.